Bayer to Highlight Additional Analyses From Comprehensive KERENDIA® (finerenone) Clinical Trial Program at the American Society of Nephrology's 2022 Kidney WeekBusiness Wire • 11/02/22
Bayer's KERENDIA® (finerenone) Recommended as Part of Comprehensive Treatment Strategy for Chronic Kidney Disease Associated With Type 2 Diabetes in Newly Published Clinical RecommendationsBusiness Wire • 10/27/22
Nori Partners With Bayer's ForGround Platform to Scale Its Carbon Marketplace Through Verified Carbon RemovalsBusiness Wire • 10/24/22
Bayer's KERENDIA® (finerenone) Receives Grade A Recommendation as Treatment Option for Patients With Chronic Kidney Disease Associated With Type 2 Diabetes in Latest Guideline Update From American Association of Clinical EndocrinologyBusiness Wire • 10/10/22
Bayer Completes Sale of Its Environmental Science Professional Business to CinvenBusiness Wire • 10/05/22
Bayer Fund Announces $8.2M in Donations to U.S. Nonprofit Organizations During First Half of 2022Business Wire • 09/28/22
Bayer Announces Further Investment in Direct Relief Community Health Awards ProgramBusiness Wire • 09/26/22
Bayer's KERENDIA® (finerenone) Receives Updated Label to Include Findings From Phase III FIGARO-DKD Cardiovascular Outcomes Study in Patients With Chronic Kidney Disease and Type 2 DiabetesBusiness Wire • 09/01/22
Bayer Demonstrates Commitment to Advancing Oncology by Showcasing New Data From Innovative Science at ESMO Congress 2022Business Wire • 08/30/22
Bristol Myers Squibb, Bayer Stocks Hit The Deck On Blood Thinner FlopsInvestors Business Daily • 08/29/22
Bayer Aktiengesellschaft (BAYRY) is a Top-Ranked Value Stock: Should You Buy?Zacks Investment Research • 08/25/22
Bayer to Present Data From Cardiovascular Portfolio, Including a Late-Breaking Presentation From FIDELITY for KERENDIA® (finerenone) and New Phase IIb Data From PACIFIC Trial Program for the Oral Factor XIa Inhibitor asundexianBusiness Wire • 08/22/22
FDA Label Update Reflects Bayer's Commitment to Providing Options for Long-acting ContraceptionBusiness Wire • 08/18/22